Avonex Safety and Tolerability in Chinese Subjects With Relapsing Multiple Sclerosis (MS)
Clinical trial NCT01181115 · COMPLETED
Trial details
- NCT number
- NCT01181115
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-10-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.